[ad_1] Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of…
[ad_1] Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. SAN FRANCISCO — Investors…
[ad_1] From the corporate jets of Teterboro Airport to the crowded halls of the J.P. Morgan Healthcare Conference, it’s a good time to be a pharmaceutical executive. After months of fear, anxiety, and frantic negotiation, the men and women who run the world’s largest drugmakers are striding into 2026 newly unencumbered as they descend on…